Dementia | Dementia Conference | Dementia Conferences | Dementia Care Conference | Nursing Conference | Neurology Conference | CME Conference | Toronto | Canada | Europe | USA | Middle East

Theme: Discernment Into Innovative Research and Care Practice Approaches Towards Dementia

Dementia Care 2017

Dementia Care 2017

It is with great bliss to invite you to the official website of the 7^th International Conference on Dementia and Care Practice during August 14-16, 2017 at Toronto, Canada.

The live format of the conference will be accredited with CME and CPD Credits

Dementia Care 2017 is a specially designed cluster conference, organized around the theme "Discernment into Innovative Research & Care Practice approaches towards Dementia", which covers a wide range of critically important sessions from basic research to latest innovations in the field of Dementia and Care Practice.

Dementia, amongst the biggest cosmic public health challenges, is a syndrome – usually of a chronic or progressive nature – in which there is deterioration in cognitive function and mainly affects memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement and reasoning problems but not consciousness.

The objective of this session is to comprehend the inducement, Genesis and Diagnosis and prognosis including caregiving of Dementia and further hastening the revivification of dementia.

Track 1: Dementia: Alzheimer’s and Vascular Dementia

Alzheimer's is a kind of dementia that causes dilemma with memory, thinking and behaviour. This mainly happens due to the disruptions caused in nerve cells within the brain. The brains of individuals with Alzheimer disease have an abundance of 2 abnormal structures: amyloid plaques and neurofibrillary tangles that are product of misfolded proteins. This can be very regular in certain regions of the brain that are necessary for memory. Another main feature of Alzheimer’s disease is the loss of connections amidst cells. This results in diminished cell operate and necrobiosis.

Vascular dementia is slump in thinking skills caused by conditions that block or reduce flow of blood to the brain, depriving brain cells of vital oxygen and nutrients. Multiple small strokes or other conditions that affect blood vessels and nerve fibres deep inside the brain cause these accumulations to occur.

3^rd International Conference on Central Nervous System Disorders and Therapeutics September 25-27, 2017 at Vienna, Austria; 3^rd International Conference on Parkinson’s disease & Movement Disorders on June 05-07, 2017 at Milan, Italy; 14^th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; 2^nd International Conference on Spine and Spinal Disorders during July 24-26, 2017 at Rome, Italy: 3^rd International Conference on Spinal Surgery during October 16-18, 2017 at Chicago, USA: 17^th European Neurology Congress on October 15-17, 2017 at Rome, Italy; 11^th World Congress on Neurology and Therapeutics on March 27-29, 2017 at Madrid, Spain; Alzheimer’s Association International Conference July 16 – 20, 2017 at London, England; Alzheimer Foundation of America; Alzheimer's and Related disorders Society of India; Shiley- Marcos Alzheimer’s Disease Research Centre; The Alzheimer Society of Ottawa

Track 2: Neurodegenerative Diseases

Neurodegenerative disease is an allied term for a range of conditions which primarily affect the neurons in the brain and are incurable and attenuate conditions that dynamically result in degeneration or death of nerve cells. Examples of neurodegenerative diseases include Dementia, Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis and Huntington’s disease. The most banal kind of neurodegenerative disorder which people are facing is dementia.

Dementia is a group of conditions characterised by wreckage of at least two brain functions, such as memory loss and judgment. The deficit of brain function is stern enough that an individual cannot do normal activities and leads to such an extent that it interferes with a person’s lifestyle. Additionally, some individuals with dementia cannot manage their emotions. The occurrence of dementia increases emblematically with increasing age. However, it’s not a standard part of aging. Many people live into their 90s beyond with nil signs of dementia.

6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 3rd International Conference on Central Nervous System Disorders and Therapeutics on September 25-27, 2017 at Vienna, Austria; 3^rd International Conference on Neuro Infectious Disorders on August 28-30, 2017 at Philadelphia, USA; 3^rd International Conference on Spinal Surgery during October 16-18, 2017 at Chicago, USA: 13thâ€‹ International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders on March 29- April 02, 2017 at Vienna, Austria; Alzheimer's Australia National Conference on October 17 – 20, 2017 at Melbourne, Australia; Alzheimer's Australia National; Alzheimer Society of Canada; Dementia Care Society of Nigeria & Rossetti Care; Dementia Alliance International

Track 3: Dementia Care Research

Amongst the induced and later stages of dementia an individual often involves challenging behavioural problems such as anger, sadness, paranoia, confusion and fear that can further result in oppositional, aggressive and sometimes violent actions.

Although there is currently no cure for dementia and no way to stop the underlying death of brain cells, but dementia research has shown that there is still a leeway to improve the essence of life of people living with dementia by providing a supportive environment to them. An individual’s centred care is considered important which characterises a clear perceptive of the individual and giving consideration to their cultural background, personal history, social and family networks and preferences for activities in designing their care.

10^th International Conference on Neuroscience and Neurochemistry on February 27 – 28, 2017 at Amsterdam, Netherlands; Conference on Brain Disorders on November 06-08, 2017 at Madrid, Spain; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; World Congress and Expo on Dementia and Neuroscience September 26–28, 2016 at Los Angeles, California: 2^nd International Conference on Spine and Spinal Disorders during July 24-26, 2017 at Rome, Italy: Clinical Trials on Alzheimer’s Disease (CTAD) on December 8 – 10, 2016 at San Diego, CA, USA; National Cell Repository for Alzheimer’s disease; Mayo Alzheimer’s Disease Research Center; The Alzheimer Society of Ottawa and Renfrew County; American Academy of Neurology ; Center for Cognitive Neurology

Track 4: Dementia Care Practice

Diagnosing dementia and Alzheimer is generally difficult, particularly in the initial stages. However diagnosis assessment incorporates medical and patient history to rule out different possible causes. Therefore numerous diagnostic procedures are needed which further includes neurological and physical examination related to blood and urine tests, Mental status assessment to work out the level of mental deterioration, Brain scans (CT Scans and MRI), Caregiver interview to see the level of dependency, Mini Mental State Examination (MMSE) can also be recommended.

Aside from these diagnostics, dementia patient needs reassurance and support from the people closest to them - including their carers, friends and family to help the patient to reminisce their sense of existence and feelings of self-worth.

11^th World Congress on Neurology and Therapeutics on March 27-29, 2017 at Madrid, Spain; 14th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; International Dementia Conference June 7-8, 2018, 32^nd International Conference on Alzheimer’s Disease International April 26-29, 2017, Kyoto, Japan; 13^th International Conference on Alzheimer’s & Parkinson’s Diseases on March 29 – April 2, 2017 at Vienna, Australia; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 15^th World Congress on Neurology and Neurological Disorders on August 20-22, 2017 at Paris, France; 2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 11th World Congress on Controversies in Neurology on March 23-26, 2017 at Athens, Greece; Alzheimer's Association International Conference (AAIC) on July 16-20, 2017 at London, UK; Alzheimer’s Drug Discovery Foundation; Dementia & Alzheimer's caregiver center; Banner Alzheimer’s Initiative; Center for Cognitive Neurology; Dementia Alliance International

Track 5: Neurological Nursing

Neurological Nursing is a very provoking nursing specialty which deals with assessment, nursing diagnosis, and management of many neurological disorders for which care practitioners provide patient care regarding neurological disorders such as trauma, brain injuries, dementia, stroke, seizures, tumors, headaches, infections and aneurysms, as well as other neurological intricacies.

Talking about dementia, it encircles many different conditions and is apparent by a loss of cognitive abilities affecting attention, memory, language, logical reasoning and problem-solving skills that interfere with daily activities. It is caused by brain cell deterioration.

Neurological care practitioners commit to give compassionate care to patients suffering from neurological diseases including dementia and Alzheimer, from diagnosis to treatment and beyond.

2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 7^th International Conference on Alzheimer’s Disease and Dementia on October 29-31, 2017 at Brussels, Belgium; 13^th International Conference on Alzheimer’s & Parkinson’s Diseases on March 29 – April 2, 2017 at Vienna, Australia; 11^th World Congress on Neurology and Therapeutics during March 27-29, 2017 at Madrid, Spain: 2^nd International Conference on Spine and Spinal Disorders during July 24-26, 2017 at Rome, Italy: 10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: 3rd Congress of the European Academy of Neurology (EAN) on June 24-27, 2017 at Amsterdam, Netherlands; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center; Fisher Center for Alzheimer’s Research; Banner Alzheimer’s Initiative; Center for Cognitive Neurology; Alzheimer Foundation of America

Track 6: Person living with Dementia

Surviving with dementia from conditions such as Alzheimer’s and related disorders can have an ample of emotional, social, psychological and practical impact on a person. Dementia sufferer finds that their mental abilities are declining, for instance, difficulties to remember things, think clearly, communicate with others, or take care of themselves and often feel vulnerable and need a great deal of reassurance and support.

7^th International Conference on Dementia and Care Practice May 04-05, 2017 Toronto, Canada; 12^thGlobal Neurologists Annual Meeting on Neurology and Neurosurgery on December 04-06, 2017 at Dubai, UAE; 3^rd Annual Experts Meeting on Depression, Anxiety and Stress Management on November 05-07, 2017 at Madrid, Spain; Annual Dementia Conference on April 21, 2017; 10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: Human Amyloid Imaging Conference on January 11-13, 2017 at Cambridge, England, UK; Neuroradiology-Brain and Spine 2017 on March 25-26, 2017 at Sydney, Australia; 13th International Conference on Alzheimer`s & Parkinson`s on March 29 – April 02, 2017 at Vienna, Austria; Center for Cognitive Neurology; Canadian Home Care Association; Alzheimer Society of U.K ; Dementia & Alzheimer's caregiver center; Alzheimer's Australia National

Track 7: Age and Dementia

Neurocognitive disorders accounts a class of mental state disorders that essentially affect learning, memory, judgement, and cognitive behaviour, dementia , and delirium. There's no set age for these disorders to happen but it has been found that age-associated memory impairment and dementia increases typically with increasing age.

Geriatrics scrutinised and stated that people facing dementia whose symptoms started before the age of 65 are often considered as 'younger people with dementia' or as having young-onset dementia and those before the age of 65 are consider under “early onset dementia or “working age dementia” category.

2^nd International Conference on Neurorehabilitation on May 25-26, 2017 at Skokie, IL, United States; 10^th International Conference on Neuroscience and Neurochemistry on February 27-28, 2017 at Amsterdam, Netherlands; 2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 11^th World Congress on Neurology and Therapeutics March 27- 29, 2017 at Madrid, Spain; Fisher Center for Alzheimer’s Research ; Alzheimer Society of Canada ; Dementia Care Society of Nigeria & Rossetti Care ; Dementia Alliance International; Banner Alzheimer’s Initiative; Center for Cognitive Neurology ; Alzheimer Foundation of America

Track 8 : Factors influencing Dementia

Dementia is the case that people over 60 fear the most. The most common factors which enhances the risk of developing dementia includes ageing, accumulation of ApoE, Alcohol use, Genetics, Down syndrome, Atherosclerosis, Depression, stroke, Diabetes, Hypertension, Mental illness, smoking, Unhealthy diet, Head injuries and many more.

There is no proper cure for dementia; yet medication (including cholinesterase inhibitors containing Donepezil-Rex) and non-drug treatments could give some comfort. However, dementia is not inexorable as we age and there is a lot we can do to dwindle the chances of mellowing it.

14^th International Conference on Neurology and Neurosurgery on June 21 - 22, 2017 at Paris, France; 14^th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; 2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: 7^th International Conference on Alzheimer’s Disease and Dementia on October 29-31, 2017 at Brussels, Belgium; International Dementia Conference on June 7- 8, 2018; Alzheimer’s Australia National Conference on October 17 – 20, 2017 at Melbourne, Australia; Alzheimer Disease International; Alzheimer's Research UK; Bright Focus Foundation ; Cure Alzheimer’s Fund; Alzheimer Society of Ontario

Track 9: Diagnosis and Prognosis of Dementia

Dementia is not a disease; it’s actually a comprehensive term that portrays a wide range of symptoms related with a drop in memory or thinking skills severe enough to turn down a person's aptitude to perform everyday activities.

No single test can disclose if someone is demented or not however, Doctors or physicians can almost rules out if a person has dementia using medical evaluations which comprises of medical history, mental status testing (Mini-mental state examination, Mini-Cog test) , physical and neurological exams, blood tests and brain imaging (CT Scans and MRI).Though treatment for dementia is entering an energising stage, following many new medications depending upon the pathogenesis of Alzheimer’s illness.

2^nd International Conference on Neurorehabilitation on May 25 – 26, 2017 at Chicago, USA; 13^th International Conference on psychiatric-Mental Health Nursing on September 18-20, 2017 at Chicago, USA; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 11^th World Congress on Neurology and Therapeutics March 27- 29, 2017 at Madrid, Spain; 10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: : 2^nd International Conference on Neuro Oncology and Brain Tumour during April 24-25, 2017 at Dubai, UAE:German Centre for Neurodegenerative Diseases ; National Alzheimer’s Coordinating Center; Fisher Center for Alzheimer’s Research; Banner Alzheimer’s Initiative; Center for Cognitive Neurology; Alzheimer Foundation of America

Track 10: Animal Models and Translational Medicine

Dementia is a syndrome with eccentric memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease. Animal models for dementia or Alzheimer is important to think about the human phenotype and what is being modelled in terms of the animal phenotype. Animal models of Alzheimer’s disease or dementia, based on the genetics of the disease and the closely related front temporal dementia, replicate at least some of the pathology.

Researchers have been successful at modelling very specific aspects of Alzheimer in the mouse (e.g., plaques, tangles). Multiple approaches have been adopted to create reliable animal models ranging from rodents to non-human primates, where the animals are exposed to a predetermined injury or causing genetic ablation across specific regions of brain suspected to affect learning functions.

6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 3rd International Conference on Parkinson’s Disease and Movement Disorders on June 5-7, 2017 at Milan, Italy;14th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; : 2^nd International Conference on Neuro Oncology and Brain Tumour during April 24-25, 2017 at Dubai, UAE: 11^th World Congress on Neurology and Therapeutics during March 27-29, 2017 at Madrid, Spain: Center for Cognitive Neurology; Canadian Home Care Association; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center; Bright Focus Foundation; Alzheimer Society of Ontario

Track 11: Biomarkers in Dementia

Experts believe that biomarkers offer most promising paths to diagnose Alzheimer’s or dementia. A biomarker is something that can reliably indicate the presence of disease.

Certain possible biomarkers are being studied for their strength to indicate initial stages of Dementia or Alzheimer's disease such as including beta-amyloid and tau levels in cerebrospinal fluid (CSF) and brain changes detectable by imaging. However, three biomarkers have been well-established and validated internationally to diagnose AD in CSF with ELISAs: β-amyloid (1–42) [Aβ(1–42)], total tau and phospho-tau-181.

14^th International Conference on Neurology and Neurosurgery on June 21 - 22, 2017 at Paris, France; 14^th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; 6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 11^th World Congress on Neurology and Therapeutics during March 27-29, 2017 at Madrid, Spain: 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, GermanyNational Alzheimer’s Coordinating Center; Banner Alzheimer’s Initiative; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center; Alzheimer Foundation of America; Alzheimer's and Related disorders Society of India

Track 12: Amyloid Protein in Dementia

All cells are like minute factories, producing thousands of proteins with precise functions to keep the cells viable. A flaw can occur if a protein is altered, or if excess or too little is formed. Sometimes, the consequences are so severe that a cell dies. Neuron ruination is the chief cause of dementia and is often associated to malfunctions in the connection system that a neuron needs to survive.

Dementia is associated with accumulation of two proteins – amyloid and tau - into plaques and tangles in the brain. Beta-amyloid accumulates as plaques in Alzheimer's disease or dementia and is an endorsement of the disease. Tau compiles into tangles (known as neurofibrillary tangles or NFT). And further disrupts the structure and communication within the nerve cells, leading to cell death.

10^th International Conference on Neuroscience and Neurochemistry on February 27 – 28, 2017 at Amsterdam, Netherlands; Conference on Brain Disorders on November 06-08, 2017 at Madrid, Spain; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 3^rd International Conference on Central Nervous System Disorders and Therapeutics on September 25-27, 2017 at Vienna, Austria ; 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, GermanyClinical Trials on Alzheimer’s Disease (CTAD) Cure Alzheimer’s Fund ; Alzheimer Society of Ontario ; Center for Cognitive Neurology ; Canadian Home Care Association; Alzheimer Foundation of America ; Alzheimer's and Related disorders Society of India

Track 13: Neuropathology

Dementia is among the most typical neurodegenerative diseases which specifically arise due to neuron death. It is now becoming evident that neurodegenerative diseases have a biochemical basis. Many neurodegenerative diseases are inherited. Their genes are known and DNA-based diagnosis (including prenatal diagnosis) is available. Loss of neurons is accompanied by specific histopathological findings such as Alzheimer's plaques and Lewy bodies. Some neurodegenerative diseases engage specific anatomical systems or adjoining sets of neurons.

6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 3^rdInternational Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 17^th European Neurology Congress on October 15-17, 2017 at Rome, Italy; 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, Germany: 10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands:Alzheimer Disease International; Alzheimer's Research UK ; Bright Focus Foundation ; Cure Alzheimer’s Fund; Alzheimer Society of Ontario; John Douglas French Alzheimer's Foundation; National Organization for Rare Disorders (NORD)

Track 14: Neuropharmacology

Dementia is a common clinical phenomenon; however, management of the coexisting illnesses remains incomplete. Neuropsychiatric turmoil is one of the clinical characteristics of Dementia. Traditionally, this turmoil has been managed with neuroleptics or benzodiazepines but accounts serious side effects. With the advancement in the neuropharmacology field, many new-fangled medications came into existence. Donepezil is a piper dine based reversible, non-competitive cholinesterase inhibitor and proved beneficial for the management of symptoms of Alzheimer’s disease covering dementia, a disease in which cholinergic pathways in the cerebral cortex and basal forebrain are well known to be compromised.

6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 3rd International Conference on Central Nervous System Disorders and Therapeutics on September 25-27, 2017 at Vienna, Austria; Conference on Brain Disorders on November 6-8, 2017 at Madrid, Spain; 10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, GermanyAssociation for Frontotemporal Degeneration (AFTD) ; Lewy Body Dementia Association; Alzheimer's disease Education and Referral Center (ADEAR); National Alzheimer’s Coordinating Center; Banner Alzheimer’s Initiative; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center

Track 15: Therapeutic Approaches towards Dementia

There are a numerous ways to categorise interventions in dementia care, for instance, by the kind of treatment approach used. The chief grouping is by the therapeutic goal, with three considerable spheres recommended: the maintenance of function, including cognitive functions, the management of behaviours that challenge and the reduction of comorbid emotional disorders.

The range of non-pharmacological ‘interventions’ in dementia care is ample and would include the everyday interactions of carers with the person suffering from dementia, the effect of the physical and social conditions and all manner of ‘therapies’, ranging from art sessions to contact with animals.

3^rdInternational Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 3rd International Conference on Parkinson’s Disease and Movement Disorders on June 5-7, 2017 at Milan, Italy; 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, Germany: National Institute of Mental Health (NIMH); National Alzheimer’s Coordinating Center; Banner Alzheimer’s Initiative; Alzheimer Society of U.K; Dementia & Alzheimer's caregiver center; Alzheimer Disease International

Dementia Care 2017 Organising Committee, invites all the participants from all over the world to attend the Dementia & Care Practice conference entitled 7th International Conference on Dementia & Care Practice which is scheduled during August 14-16, 2017 at Toronto, Canada. The core theme of the conference is "Discernment into Innovative Research & Care Practice approaches towards Dementia".

Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation.

The recent surveys show that nearly 46.8 million people in world are living with dementia and the number will escalate double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. Even the global healthcare costs of dementia have spike from US$ 604 billion in 2010 to US$ 818 billion in 2015 with an increase of 35.4%.Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries. Today, over 35 million people worldwide currently live with the condition. This number is expected to double by 2030 and more than triple by 2050 to 115 million. No treatments available to slow down or stop the brain damage caused by Alzheimer’s disease, although several medications can transiently improve the symptoms of dementia amongst people. In two decades, it is estimated that 1.4 million Canadians will suffer from dementia, yielding the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.

Why to attend???

Dementia Care 2017 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about their work. Dementia Care 2017 will congregate renowned speakers, principal investigators, experts, neurologists and Dementia researchers from both academia and health care industry to discuss their views and research. The conference will be comprised of sessions by world class experts in the field of neurology. In Dementia Care 2017, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

Target Audience:

All health care professionals, non-professional caregivers, researchers working with older adults, including nurses, occupational therapists, physicians, long-term care administrators, case managers, physiotherapists, personal workers, speech pathologists, students who are interested in dementia care, and recreational therapists.

Neurologists and Directors
Physicians
Neuroscientists
Specialists
Researchers
Health care professionals
Professors
Industrial Experts
Neurosurgeons
Psychiatrist
Nutritional Scientists
Care Practitioners
Lecturers and Students from Academia in the study of Dementia
Students from Academia in the research of Neurology

Dementia Care 2017 is a specially designed cluster conference which will probably unite brilliant personalities to give talks that are thought centered, and on an extensive variety of subjects associated with Dementia & Care Practice, to encourage learning, motivation and ponder – and incite discussions that matter.

Participation Benefits at Dementia Care 2017

Benefits to Speakers:

· Claim CME Credits Approved by AMA & ACCME

· Claim CPD Credits by CPD Standards Office, UK

· IOCM Certificate

· Abstracts will be published with DOI number by Cross Ref

· Handbook & Conference kits

· Website perceivability to more than 35K guests in under 6 months

· Provocative Symposia's and Workshops

· One on One Meeting with Eminent Speakers

· Unparalleled opportunity to give presentations and network with other key opinion leaders in the field.

· Live Streaming of the gathering

· Get worldwide acknowledgement to your profile and Research

· Keynote sessions by world's most famous scientists

· Publish your compositions in the particular supporting International Journals

· Access to Preconference Workshops

· Group Registration Benefits at the conference

· Research Oriented Presentations at our Gatherings

· Encounter world class services and friendliness at the meeting

Benefits to Delegates:

· Participation Certifications

· To sharpen their skills: Delegates can analyse new ideas and procedures to make themselves extra powerful towards their work.

· Meet experts and influencers face-to-face

· The opportunity in an effort to blend and mingle, shape new relationships and toughen existing ones.

· Grow: Conference will offer a unique convergence of networking, gaining knowledge of and fun right into a single package

· Conference attendance inspires, rejuvenates, and energizes delegates

· Networking and informal sharing among colleagues

· Enjoy the alluring city environment at conference venue

· Best Hospitality services at our conference

Theme: Discernment into innovative research and care practice approaches towards Dementia.

On behalf of the Conference Organizing Committee, it is with great bliss that we welcome you to the official website of 7^th International Conference on Dementia and Care Practice during August 14-16, 2017 at Toronto, Canada.

Dementia Care 2017 mainly spotlight on Alzheimer’s disease, Dementia, Neurological changes in brain, Dementia Imaging techniques, Disease Mechanisms, Geriatrics and Neurodegenerative Disorder, Pathophysiology, Neuropharmacology and therapeutic approaches, Care practice and Awareness, Current Research in Dementia and Alzheimer’s Disease.

Importance & Scope:

Dementia is a common term for loss of memory and other mental abilities severe enough to interfere with daily life. It is caused by concrete changes in the brain, mainly associated with neurons.

Dementia, including Alzheimer’s disease, is amongst the immense global public health challenges siding our generation.

The recent surveys show that nearly 46.8 million people in world are living with dementia and the number will escalate double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050.

The global healthcare costs of dementia have spike from US$ 604 billion in 2010 to US$ 818 billion in 2015 with an increase of 35.4%.

Our goal is to provide an outstanding global event which screens the thorough spectrum of research in dementia and share the cross-cultural experiences of various procedures related to it.

For more details, please visit: http://dementiacare.conferenceseries.com/

Why Toronto ?

One of the world’s most visited places, Toronto has something for everyone: from showplace of history and culture to fine food and good times.

Toronto is the provincial capital of Ontario covering an area of 630 square kilometres due north-south stretch of 21 kilometres and east-west stretch of 43 km. It is an alluring, safest metropolitan area with a wonderful chain of parks, recreational, and cultural efficiencies.

Toronto has ample of academic institutions holding Canada’s largest University, The University of Toronto, established in 1827. Moreover it is home to around 20 public hospitals. It also hosts vast variety of health-focused non- profit organisations which are associated with Dementia & Alzheimer diseases. Canada ranks fourth position in the world for its scientific research.

Moreover, it was estimated that nearly 564,000 Canadians are living with dementia & the combined health-care system and out-of-pocket caregiver costs total an estimated $10.4 billion per year.

Conference Highlights :

o Dementia: Alzheimer’s and Vascular Dementia

o Neurodegenerative Diseases

o Dementia Care Research

o Dementia Care Practise

o Neurological Nursing

o Person living with Dementia

o Aging and Dementia

o Factors influence Dementia

o Diagnosis and Prognosis of Dementia

o Animal Models and Translational Medicine

o Biomarkers in Dementia

o Amyloid Protein in Dementia

o Neuropathology

o Neuropharmacology

o Therapeutic Approaches towards Dementia

Why to attend ?

Adjoin your Target Scientists; Professors, members from around the world focused on learning about Dementia and Alzheimer’s, this is your only best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, allocate information, meet with current and potential scientific discoveries, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent findings and the latest updates in Dementia and Care Practice fields, which are hallmarks of this conference.

Be Part Of it !

This conference spotlight on all the major aspects in the field of Dementia, Alzheimer’s as well as Aging.

This Meeting focusses on event for bringing together Scientists, Physicians, International mix of leading Universities, Alzheimer’s and Dementia Institutions to transform the practices to control and cure Dementia.

It would be beneficial for all the students who are willing to enter into worlds targeting to the respective fields.

Dementia Associations & Societies around the Globe :

Alzheimer Society of Canada

Alzheimer's Foundation of America

Alzheimer's and Related disorders Society of India

Alzheimer Society of BC

Alzheimer's Association

Shiley Marcos Alzheimer's Disease Research Center

Mayo Alzheimer's Disease Research Centre

Dementia Care Society of Nigeria & Rosetti Care

Alzheimer's Europe

Indiana Alzheimer Disease Centre

The Alzheimer Society of Ottawa and Renfrew County

Dementia and Alzheimer Care Giver Center

UC Davis Alzheimer’s Disease Research Center

Care Connection Alzheimer's Foundation of America

Alzheimer’s Alliance of Smith County

Alzheimer's & Dementia Alliance of Wisconsin

Lewy Body Dementia Organisation

National Alzheimer's Coordinating centre

National cell repository for Alzheimer's Disease

Alzheimer Society of Toronto

Dementia Care centre

Universities & Associations in and around Toronto :

Canadian Home Care Association

Alzheimer Society of Toronto

Canadian Institute of Health Research

Alzheimer Society of Canada

Canadian Neurological Sciences Federation

The Alzheimer Society of Ottawa and Renfrew County

Home Care Ontario

Alzheimer Society of Hamilton Halton

Habitat for Humanity

Hilgos Foundation

Alzheimer Society of Niagra Region

Brain Repair Center

University of Toronto

Canadian Institute for Behavioural Neuroscience

University of Ottawa

University of Alberta

University of Calgary

Canadian Centre for Behavioural Neuroscience

Montreal Neurological Institute and Hospital

Ambrose University

Pacific Parkinson's Research Centre

University of Waterloo

Queen's University

University of Manitoba

University of British Columbia

Mc Master University

Brain Repair Center

Center for Dementia Research

Products Manufactured By Industries :

Middling drugs are available to treat people with Mild to moderate Dementia or Alzheimer's Disease. Some of them are :

Aricept™ formed by Pfizer Canada Inc.,

Exelon™ formed by Novartis Pharma Canada Inc.

Reminyl™ formed by Janssen Ortho Inc.

Ebixa®

Aricept™

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 14-16, 2017
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

7^th International Conference on Dementia & Care Practice August 14-16, 2017 Toronto, Canada

Recommended Global Neuroscience Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links